OI Therapy Raised BMD, Not Fracture Benefit - Quiz - MDSpire

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

  • By

  • Andrea Surnit

  • June 5, 2026

  • 7 min

Share

Original Source(s)

OI Therapy Raised BMD, Not Fracture Benefit

  • by Andrea Surnit

  • June 5, 2026

Related Content

Editorial: Exploring XR technologies for joint surgery: innovations and clinical applications

Application of a self-developed femoral artery compression hemostasis device in proximal femoral nail anti-rotation surgery for intertrochanteric fractures: a case report

Online Program Eases Pediatric Trauma Stress

Randomized trial evaluated therapist-assisted intervention among pediatric patients with persistent symptoms 1 month following trauma